| 
		PEPFAR keeps millions of people with HIV alive and may be spared from 
		Trump spending cuts
		[July 17, 2025] 
		By CARA ANNA  
		The program known as PEPFAR is one of the most effective and popular 
		U.S. foreign aid projects in history, and the government says it has 
		saved the lives of over 25 million people around the world with HIV.
 But despite years of bipartisan support, PEPFAR has faced a severe 
		threat as the Trump administration dismantles most U.S. foreign aid.
 
 PEPFAR on Tuesday appeared to be spared a $400 million cut as 
		Republicans acted in rare defiance of a request by President Donald 
		Trump. But governments, health experts and people with HIV around the 
		world are alarmed by the effects of other U.S. aid cuts and chaos that 
		are already disrupting the crucial supply of HIV drugs — which are meant 
		to be taken daily.
 
 Here's a look at PEPFAR and how it affects millions of people globally.
 
 Fears of an AIDS resurgence
 
 Today, many babies are born infection-free to mothers with HIV — the 
		U.S. State Department says PEPFAR has been responsible for 5.5 million 
		such births — and most people around the world no longer see an 
		infection as a death sentence.
 
 Governments in Africa and elsewhere had even begun to worry about 
		complacency as people, especially youths, took the widespread 
		availability of HIV drugs for granted. In another significant step 
		forward, the U.S. Food and Drug Administration recently approved for use 
		the world’s only twice-a-year shot to prevent HIV.
 
 But the abrupt U.S. aid cuts have health officials in developing 
		countries warning of a return to the early days of the AIDS pandemic, 
		when drugs were nonexistent or severely limited and clinics were filled 
		with the dying. PEPFAR was launched in 2004 in response to those grim 
		scenes.
 
		
		 
		Also known as the U.S. President’s Emergency Plan for AIDS Relief, the 
		program has partnered with nonprofit groups to provide HIV medication — 
		including the preventative PrEP — to millions around the world. It has 
		strengthened national health care systems, cared for children orphaned 
		by AIDS and provided job training for people at risk. It has played an 
		important role in testing for and tracking HIV infections.
 HIV/AIDS has no cure, and it has killed over 40 million people globally 
		over the years. Now the U.N. agency on AIDS is warning that analysis 
		suggests 4 million additional AIDS-related deaths between now and 2029, 
		including 300,000 additional children’s deaths, if programs permanently 
		lose PEPFAR's support.
 
 From widespread support to baseless claims
 
 Since PEPFAR's creation by Congress and Republican President George W. 
		Bush, the program has largely enjoyed support across the political 
		spectrum — and gratitude from countries whose health systems have been 
		poorly equipped to care for millions with HIV.
 
 But misinformation has crept in. The Heritage Foundation, an influential 
		conservative Washington think tank, accused the Biden administration of 
		using PEPFAR “to promote its domestic radical social agenda overseas.” 
		Conservatives claimed there were efforts to integrate abortion with 
		HIV/AIDS prevention, a claim the Biden administration denied. Similar 
		claims linger under the Trump administration.
 
 [to top of second column]
 | 
            
			 
            Florence Makumene holds HIV medication that she received through 
			funding from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), 
			along with her hospital records book, at her home in Harare, 
			Zimbabwe, Feb. 7, 2025. (AP Photo/Aaron Ufumeli, File) 
            
			
			 Trump and his officials also claim 
			widespread waste and fraud as they seek to dismantle U.S. foreign 
			aid. But PEPFAR has been repeatedly scrutinized. Last year, the 
			government said the State Department's Office of Inspector General 
			had conducted 80 audits, inspections, and special reviews that 
			included oversight of PEPFAR programs, “including 21 thematic 
			reviews and audits specifically focused on PEPFAR.”
 Impossible to replace US funding
 
 The $400 million proposed cut to PEPFAR still could be restored, in 
			part or in full, as the bill on spending cuts faces a final vote in 
			the Senate, a vote in the House of Representatives and Trump's 
			signature before a Friday deadline.
 
 “We must stay vigilant,” International AIDS Society President 
			Beatriz Grinsztejn said in a statement Wednesday after PEPFAR 
			appeared to be spared.
 
 No matter what, countries and health experts say it will be 
			impossible to fill the funding gap left by the overall U.S. 
			withdrawal of billions of dollars in aid for the global HIV 
			response, including via PEPFAR.
 
 Last month, a UNAIDS report said the abrupt cuts have “destabilized 
			supply chains, led to the closure of health facilities, left 
			thousands of health clinics without staff, set back prevention 
			programs, disrupted HIV testing efforts and forced many community 
			organizations to reduce or halt their HIV activities.”
 
 South Africa, where more people live with HIV than anywhere else in 
			the world, has said 12 specialized HIV clinics that were funded by 
			the U.S. have had to close down and over 8,000 health workers in its 
			national HIV program are out of work.
 
 Now health workers there and elsewhere are trying to track down an 
			unknown number of people who have lost access to HIV medication. The 
			stakes are deadly. Stopping the drugs allows the virus to start 
			multiplying again. HIV can rebound to detectable levels in people’s 
			blood in just a few weeks, putting sexual partners at risk. The 
			virus could even become drug-resistant.
 
			
			 “It has really been hectic for us,” said Mbonisiwe Hlongwane, 
			manager of the HIV program at the Bertha Gxowa public hospital in 
			Germiston, east of Johannesburg. And the uncertainty only continues.___
 
 Associated Press writer Mogomotsi Magome in Johannesburg contributed 
			reporting.
 
			
			All contents © copyright 2025 Associated Press. All rights reserved |